Colin William Smith

Title: Colin William Smith: Innovator in Pharmacological Chemistry

Introduction

Colin William Smith is a notable inventor based in Bracknell, GB. He has made significant contributions to the field of pharmacology, particularly through his innovative work on propanoic acid derivatives. His research focuses on developing compounds that exhibit spasmolytic activity while maintaining low toxicity levels.

Latest Patents

Colin holds a patent for "Pharmacologically active propanoic acid derivatives." This invention provides styryl cyclopentenyl propanoic acids and their derivatives, which are characterized by their spasmolytic properties. The patent also outlines a method for preparing these compounds, which involves cyclizing 7-hydroxy-5,8-dioxo-10-phenyldec-9-enoic acid in the presence of a base. Colin's innovative approach has the potential to advance therapeutic options in pharmacology.

Career Highlights

Colin William Smith is associated with Lilly Industries, Inc., where he applies his expertise in pharmacological research. His work has contributed to the development of new medicinal compounds that can improve patient outcomes. With a focus on safety and efficacy, Colin's inventions are paving the way for future advancements in the field.

Collaborations

Colin has collaborated with notable colleagues, including Norman James Gutteridge and William Dawson. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in pharmacological research.

Conclusion

Colin William Smith is a distinguished inventor whose work in pharmacologically active compounds demonstrates his commitment to advancing medical science. His contributions, particularly in the area of propanoic acid derivatives, highlight the importance of innovation in developing effective and safe therapeutic options.